The problem
Chronic Obstructive Pulmonary Disorder (COPD) is a debilitating lung disease that affects 1.2 million in the UK. Nearly two thirds of cases are thought to be undiagnosed and new methods are needed to improve both diagnostics and treatment.
The solution
InspiWave is a non-invasive monitoring device developed by medical innovator Dr Phi Anh Phan, along with Professor Andrew Farmery at the University of Oxford. With its ability to both monitor lung function and pulmonary blood flow, InspiWave has the potential to improve COPD diagnosis rates and allow for more efficient bedside monitoring throughout the treatment pathway.
InspiWave aims to improve patient’s comfort and experience by providing real-time bedside monitoring information in a non-invasive way. It can be used to support patients with a variety of lung conditions, such as intensive care patients with Acute Respiratory Distress Syndrome.
Real-time monitoring ensures that clinician have the information needed to deliver the right treatment at the right time. The technology also provides vital information to improve fluid management for patients undergoing high-risk surgeries.
Medical trials are underway to demonstrate InspiWave’s effectiveness in a range of treatment scenarios, and help with targeting this device for use within the NHS.
Traction
- 2019: Funding awarded by the National Institute for Health Research Invention for Innovation programme.
Phi was awarded a place on the 2017 Enterprise Fellowships programme to develop InspiWave, and launch his startup, VentDX, formerly known as Intelligent RespiLabs.
Associated Programme
